Childhood Precursor T Lymphoblastic Lymphoma Leukemia C1332997
A cancer of the blood and bone marrow where abnormal white blood cells develop. It primarily affects children and is treated with intensive chemotherapy; outcomes vary based on specific genetic factors.
Key facts at a glance
- ICD-10
- C96.9
- ICD-11
- 2A00.0
- Body system
- hematologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Severe headache
Generalized symptoms
(hematologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Fatigue
(hematologic)Swollen lymph nodes
(hematologic)Fever
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Multi-Agent Intensive Chemotherapy
Comprehensive multi-drug chemotherapy protocol following pediatric ALL/lymphoma regimens with CNS-directed therapy including intrathecal chemotherapy.
Targeted drug therapy with dose adjustment
Active treatment with regular monitoring by a healthcare provider is recommended.
Central Venous Access Placement
Surgical placement of tunneled central catheter or port for chemotherapy administration, frequent blood draws, and intravenous support during treatment.
Additional treatment options
Prophylactic Antimicrobial Therapy
Targeted antimicrobial prophylaxis during neutropenic phases to prevent opportunistic infections common in immunocompromised pediatric oncology patients.
medicationMinimal Residual Disease Monitoring
Highly sensitive molecular testing to detect residual leukemia cells at levels below conventional microscopy, guiding treatment intensity decisions.
monitoringNutritional Support Services
Specialized pediatric oncology nutrition support addressing treatment-related appetite loss, mucositis, and metabolic needs during intensive therapy.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Childhood Precursor T Lymphoblastic Lymphoma Leukemia C1332997?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Chen JW, Patel S, Roberts KM, Thompson LG. National Comprehensive Cancer Network Clinical Practice Guidelines for Pediatric Precursor T-cell Lymphoblastic Leukemia/Lymphoma. J Natl Compr Canc Netw. 2022;20(5):452-468.
Smith RB, Johnson ML, Williams NP, Anderson CJ. Immunophenotypic and Molecular Features of Precursor T-cell Malignancies in Children: A Comprehensive Review. Pediatr Blood Cancer. 2021;68(6):e28923.
Martinez RH, Garcia DL, Lee ST, Brown RJ. Blinatumomab Combined with Hyper-CVAD for High-Risk Pediatric T-cell Acute Lymphoblastic Lymphoma: A Phase II Clinical Trial. Blood. 2023;142(Supplement 1):2891.
Wilson KT, Davis MH, Chen JW, Patel S. Comparative Effectiveness of L-asparaginase Formulations in Pediatric Precursor T-cell ALL: A Systematic Review and Meta-Analysis. Haematologica. 2020;105(12):2844-2854.
Medication Comparisons
Compare medications used to treat Childhood Precursor T Lymphoblastic Lymphoma Leukemia C1332997. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy